Robin Garner
Stock Analyst at Craig-Hallum
(0.80)
# 3,786
Out of 4,868 analysts
4
Total ratings
25%
Success rate
-8.8%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Robin Garner
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| XERS Xeris Biopharma Holdings | Initiates: Buy | $4.5 | $4.54 | -0.88% | 2 | Aug 28, 2023 | |
| CUE Cue Biopharma | Maintains: Buy | $28 → $26 | $0.59 | +4,339.13% | 1 | Mar 18, 2022 | |
| FENC Fennec Pharmaceuticals | Initiates: Buy | $17 | $7.75 | +119.35% | 1 | Apr 21, 2021 |
Xeris Biopharma Holdings
Aug 28, 2023
Initiates: Buy
Price Target: $4.5
Current: $4.54
Upside: -0.88%
Cue Biopharma
Mar 18, 2022
Maintains: Buy
Price Target: $28 → $26
Current: $0.59
Upside: +4,339.13%
Fennec Pharmaceuticals
Apr 21, 2021
Initiates: Buy
Price Target: $17
Current: $7.75
Upside: +119.35%